Biogipuzkoa
Centro de investigación
![Foto de Biogipuzkoa](/img/uploaded/BB680065D0326B877226AAACFBE7F51A.png)
![Foto de Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico](/img/noimage_org.png)
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milán, ItaliaPublicaciones en colaboración con investigadores/as de Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (100)
2024
-
A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors
Alzheimer's Research and Therapy, Vol. 16, Núm. 1
-
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia
Alzheimer's Research and Therapy, Vol. 16, Núm. 1
-
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA
Hepatology (Baltimore, Md.), Vol. 79, Núm. 6, pp. 1279-1292
-
Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2
-
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results
Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
-
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study
Journal of Neurology, Neurosurgery and Psychiatry
-
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease
Computers in Biology and Medicine, Vol. 176
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Altered plasma protein profiles in genetic FTD – a GENFI study
Molecular Neurodegeneration, Vol. 18, Núm. 1
-
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia
Human Brain Mapping, Vol. 44, Núm. 7, pp. 2684-2700
-
Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))
eBioMedicine
-
Disability accrual in primary and secondary progressive multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, Núm. 9, pp. 707-717
-
Dissecting the genetic heterogeneity of gastric cancer
eBioMedicine, Vol. 92
-
Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study
Neurobiology of Disease, Vol. 179
-
Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (The journal of nutrition, health & aging, (2017), 21, 1, (92-104), 10.1007/s12603-016-0803-1)
Journal of Nutrition, Health and Aging
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Genetic Associations between Modifiable Risk Factors and Alzheimer Disease
JAMA Network Open, Vol. 6, Núm. 5
-
Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: Comparison with sporadic primary progressive aphasia
Brain Communications, Vol. 5, Núm. 2